Texas A&M Football

Culture established under Elko has Max Wright 'pumped' for this fall

With Week 1's home opener vs. Missouri State just three days away, Texas A&M former tight end Max Wright joined us on Wednesday's edition of TexAgs Live to discuss the foundation Mike Elko & Co. have built ahead of 2026's nine-game SEC slate.
By David Nuño
September 2, 2026
2.4k Views
Discuss
Story Poster
Photo by Jamie Maury, TexAgs
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.

Key notes from Max Wright interview

  • I am glad football season is here. It felt like the longest offseason ever. There are a lot of new faces for the Aggies. There’s a lot of guys who can make a name for themselves. We also have a very tough schedule. The ending stretch of the season might be tougher than any other team out there. Ending the season with Alabama, South Carolina, Tennessee, Oklahoma and Texas is very difficult. I am very excited.
To view this content, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Olin Buchanan TexAgs Live Max Wright TexAgs Live Feature Jimbo Fisher Southeastern Conference Micah Riley Marcel Reed Mark Nabou Jr. Kiotti Armstrong Football
Show All
Texas A&M Missouri State 2026
More Football
See All →
Game Highlights: Texas A&M 48, Arizona State 20
By Andrew Wu
Aggies pick up one spot in the latest AP poll
By Richard Zane
The Loochador Podcast: Ags capitalize on opportunities in Week 2
By Billy Liucci
12 Key Statistics: Texas A&M 48, Arizona State 20
By Luke Evangelist
Discussion from...

Culture established under Elko has Max Wright 'pumped' for this fall

1,448 Views | 0 Replies | Last: 11 days ago by David Nuño
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.